Last edition
News about
Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca
Sun Pharmaceutical Industries Ltd has acquired the rights to trademarks of diabetes drug dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, the parent company of AstraZeneca Pharma India
Bharat Biotech signs MoU with GCVC for drug substance for Covaxin
Bharat Biotech International Limited has signed an MoU with Gujarat Covid Vaccine Consortium (GCVC) towards contract manufacturing for the drug substance for Covaxin
Zydus introduces new tech enabled initiative to safeguard patients against counterfeit drugs
Zydus Cadila, an innovation-driven pharmaceutical company, announced that it has introduced a new IT enabled scratch code which shall be printed under a scratchable surface in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited
Moderna announced that the phase 2/3 study of its Covid-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination. In the study, no cases of Covid-19 were observed in participants
Dyadic enters collaboration with Syngene to develop Covid-19 vaccine
Dyadic International, Inc. (Dyadic), a global biotechnology company, has entered into a collaboration with Syngene International Limited (Syngene), an integrated research, development, and manufacturing services company, to develop a Covid-19 vaccine candidate that can protect against the emerging variants of concern
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
Global pharma major Lupin Limited announced the achievement of key milestones for Lupin's MEK inhibitor compound (LNP3794) that is planned for development by Boehringer Ingelheim in combination as potential targeted therapy for patients with difficult-to-treat cancers
PharmEasy completes acquisition of Medlife
The acquisition which took place in January 2021, was aimed at creating a strong unified platform to accelerate the mission of providing quality healthcare to a larger population
Bharat Biotech expects WHO emergency listing for Covaxin by July-September 2021
Bharat Biotech stated that it has submitted application for WHO Emergency Use Listing (EUL) for Covaxin, and regulatory approvals are expected in July-September, 2021
Camfil, a global leader in air filtration equipment and clean air solutions, and Sinopharm GEPTECK announced the joint release of digital high-efficiency air supply units. Sinopharm is the largest pharmaceutical and healthcare group under the State-Owned Assets Supervision and Administration Commission of the State Council (SASAC) in China
MSN Labs initiates phase III trial of molnupiravir to treat Covid-19 in India
MSN Laboratories, a leading integrated pharmaceutical company, has announced that it is now initiating phase III clinical trial of molnupiravir capsules for the treatment of Covid-19 in India
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy